Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapy.

@article{Jha2013SuppressionOA,
  title={Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapy.},
  author={Babal Kant Jha and Beihua Dong and Carvell T. Nguyen and Irina Polyakova and Robert H. Silverman},
  journal={Molecular therapy : the journal of the American Society of Gene Therapy},
  year={2013},
  volume={21 9},
  pages={1749-57}
}
The use of lytic viruses to preferentially infect and eliminate cancer cells while sparing normal cells is a promising experimental therapeutic approach for treating cancer. However, the efficacy of oncolytic virotherapy is often limited by two innate immunity pathways, the protein kinase PKR and the 2'-5'-oligoadenylate (OAS)/RNase L systems, which are widely present in many but not all tumor cell types. Previously, we reported that the anticancer drug, sunitinib, an inhibitor of VEGF-R and… CONTINUE READING
Highly Cited
This paper has 42 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

Similar Papers

Loading similar papers…